Highlights of the KOL meeting : Three ophthalmology experts discuss PRIMA in advanced dry-AMD :
· Pr. F. Holz : “Real world unmet medical need : atrophic dry-AMD”
· Pr. D. Palanker : “PRIMA inventor’s motivation”
· Pr. J-A. Sahel : “First in human study PRIMA in AMD”
To have access to the Powerpoint presentation, please click on the title
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Biotech firm Pixium Vision, which created the device, has trialled the bionic eye in five people in France who have age-related macular degeneration.
The company has recently received positive data from the first
feasibility trial of Prima System in age-related macular degeneration
patients – most of the patients could identify letters and some
sequences of letters.
One year after the Prima device was implanted, all five patients in the Paris-based Prima-FS trial
had light perception in the central retinal area, none had had central
visual activity at enrollment, meeting the study’s primary endpoint.
Most of the patients could identify letters, and some sequences of
letters.